Virtual Observed Therapy for Patients With Tuberculosis

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02680470

Enrollment

Registered

2016-02-11

Start date

2015-08-31

Completion date

2017-05-31

Last updated

2017-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Keywords

Tuberculosis, Management, Observed therapy

Brief summary

Using modern technology, investigators will observe participants taking their TB tablets three times per week using a mobile phone, iPod or computer with camera facilities in the participants home environment.

Detailed description

Using modern technology, the investigators will observe participants taking their TB tablets three times per week using a mobile phone, iPod or computer with camera facilities in the participants home environment. Investigators will connect to the participants mobile phone, iPod or computer at a mutually convenient time three times per week who will observe participants taking their TB medication. The Virtual Observed Therapy will be carried out using NHS Lothian approved software (mobile app called POLYCOM) three times per week. This is software similar to Skype but POLYCOM is the approved software we use in NHS Lothian.

Interventions

DEVICEVirtual observed therapy

Virtual Observation of participants taking their medication

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Any patient requiring Tuberculosis treatment

Exclusion criteria

Those refusing consent; the healthcare professional deems the patient that will not be able to comply with VOT

Design outcomes

Primary

Measure	Time frame
Treatment completion rates using VOT compared with historical completion rates.	length of TB treatment (usually 6-12 months)

Secondary

Measure	Time frame
% Cure from TB treatment	length of TB treatment (usually 6-12 months)
number of VOT actually observed divided by the expected VOT observed	length of TB treatment (usually 6-12 months)
patient satisfaction questionnaire at end of treatment	length of TB treatment (usually 6-12 months)
Mortality	length of TB treatment (usually 6-12 months)

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026